EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data

Dong Woo Kim, Min Seok Kim

Korean Journal of Ophthalmology · 2025

DOI: 10.3341/kjo.2025.0023 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Korean Journal of Ophthalmology, 2025. Verfasst von Dong Woo Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Insurance, Health, Intravitreal Injections. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to analyze the annual trends of intravitreal injection (IVI) in South Korea.

Methods

This retrospective study examined data from the Health Insurance Review and Assessment Service (HIRA)’s Health and Medical Big Data Open Portal. We investigated the number of patients who underwent IVIs and the total number of IVIs in Korea using the procedure code from 2014 to 2023, categorized by age group and type of healthcare facility. Patients aged under 40 years were excluded from the analysis. Additionally, trends in healthcare expenditures were analyzed.

Results

The number of patients undergoing IVI and the total number of IVI increased steadily, resulting in 92,124 patients (178.1 patients per 100,000 persons) and 291,784 injections in 2023, which contributed to an increase in medical expenses. The analysis of 10-year age intervals revealed that patients in their 70s were the most frequent recipients of IVI. The prevalence of IVI at primary healthcare facilities has been steadily increasing, from 20% in 2014 to 33% in 2023.

Conclusions

The patients receiving IVI and the total number of IVI have been steadily increasing, particularly in primary healthcare settings. Overall, medical expenses continue to rise. The findings of this study provide valuable evidence for the efficient allocation of medical resources in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsInsurance, HealthIntravitreal InjectionsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultHealth ExpendituresRepublic of KoreaRetrospective Studies

Stichwörter der Autor:innen

Big dataIntravitreal injectionsKoreaTrends

Substanzen

Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Förderung

  • Seoul National University Bundang Hospital

Zitieren

APA

Kim, D. W., & Kim, M. S. (2025). Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2025.0023

Vancouver

Kim DW, Kim MS. Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data. Korean Journal of Ophthalmology. 2025. doi:10.3341/kjo.2025.0023

BibTeX
@article{Kim2025,
  author = {Kim, Dong Woo and Kim, Min Seok},
  title = {Ten-Year Trends of Intravitreal Injection in South Korea Using the Health Insurance Review and Assessment Service Data},
  journal = {Korean Journal of Ophthalmology},
  year = {2025},
  doi = {10.3341/kjo.2025.0023}
}
Kostenlos starten →